☰

How and what does the FDA assess as acceptable endpoints within COPD development?

Pharmaceuticals & Biotechnology Editor |

How and what does the FDA assess as acceptable endpoints within COPD development?

RECOMMENDED

Steps for a successful merger and acquisition in pharma
2022-11-29

Why change management is necessary in the pharmaceutical industry
2022-11-23

Big pharma CEOs announce net zero action plan
2022-11-03

The impact of the energy crisis on pharma
2022-10-03

Upcoming Events

DigIT Pharma & Health 2024

September 10 - 12, 2024
Düsseldorf, Germany
Register Now | View Agenda | Learn More

Temperature Control and Logistics North America Summit

September 10 - 12, 2024
Falls Church, VA
Register Now | View Agenda | Learn More

AI for Pharma & Healthcare

September 24 - 26, 2024
Amsterdam
Register Now | View Agenda | Learn More

MORE EVENTS